Events & Presentations

Oct 2017

The Innovations in Cardiovascular Interventions – ICI Meeting (December 3-5, 2017)

PolyPid will participate at the ICI meeting with its product candidate D-PLEX in the ICI Meeting, to be held in David Intercontinental hotel, Tel Aviv, Israel. PolyPid’s presentation titled: “D-PLEX™: Novel Solution for Prevention of surgical Site Infections” will be presented by Dr. Tamar Alon, PolyPid’s Chief Business Officer on Monday December 4th at 14:00 -15:30 section in Hall 7. The company will be also presenting at the ICI Innovation Award Competition.

Aug 2017

The 37th Annual Meeting of the Israel Orthopaedic Association (December 13-14, 2017)

PolyPid’s abstract “Enhanced bone healing of Gustilo III severe open tibia fractures treated by immediate antibiotic-formulated bone grafting” was accepted for Oral presentation at the 37th Annual Meeting of the Israel Orthopaedic Association, to be held in David Intercontinental, Tel Aviv, Israel, on December, 13-14 2017. Prof. Moshe Salai, Head Orthopedic Division, Tel Aviv Sourasky Medical Center, ISRAEL, will present in Hall B, on December 13th, at 9:00AM.

Jul 2017

The 7th Annual Partnership Opportunities in Drug Delivery (PODD) (October 19- 20, 2017)

Dr. Tamar Alon, PolyPid’s Chief Business Development Officer, will present at the Partnership Opportunities in Drug Delivery (PODD) meeting, to be held on October 19- 20, 2017 in Marriott Copley Place, Boston, MA, USA. Dr. Alon's presentation titled: “PLEX™ Local Drug Delivery Platform: Revolutionizing Medicine by Enabling Localized, Controlled and Prolonged Therapeutics” will take place in Track 1B on October 19th at 5:15 pm.

Aug 2017

The 36th EBJIS (European Bone and Joint Infection Society) Annual Meeting (September 7-9, 2017)

PolyPid’s abstract “Enhanced bone healing of Gustilo III severe open tibia fractures treated by immediate implantation of antibiotic-formulated bone grafting” was accepted to the 36th Annual Meeting of the European Bone and Joint Infection Society which will be held in Nantes, France, on 7-9 September 2017. The abstract will be presented in the poster presentation.

Jun 2017

The 2017 BIO International Convention in San Diego (June 19-22, 2017)

PolyPid will take part at the BIO International Convention, the world’s largest conference in the field of life sciences, showcasing the world's leading companies and developments in the fields of medical technology and life sciences. PolyPid will be represented by Mr. Amir Weisberg (CEO) as well as Dr. Tamar Alon (CBD) and Dr. Dan Popovic (CBO).

Apr 2017

American Association for Thoracic Surgery – AATS Centennial, 55th International conference (April 29- May 1, 2017, Boston, MA)

PolyPid will participate at the AATS conference with its product candidate D-PLEX100. To learn more about our interim Phase Ib results as well as plans for starting up the Phase III clinical trial in the US, come and visit us at the Booth 831 in the exhibition hall.

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

Read More >

D-PLEX100

Is designed to prevent the risk of surgical site infections in both bone and soft tissue through its cutting-edge, local, extended-release mechanism

Read More >

D-PLEX1000

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >